Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat model.
about
Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.Complex roles of tissue inhibitors of metalloproteinases in cancer.Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors.Tackling EGFR signaling with TACE antagonists: a rational target for metalloprotease inhibitors in cancer.Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model.
P2860
Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat model.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Synthetic inhibitor of matrix ...... th in an orthotopic rat model.
@en
type
label
Synthetic inhibitor of matrix ...... th in an orthotopic rat model.
@en
prefLabel
Synthetic inhibitor of matrix ...... th in an orthotopic rat model.
@en
P2093
P2860
P1433
P1476
Synthetic inhibitor of matrix ...... th in an orthotopic rat model.
@en
P2093
Borchert D
Loenings SA
Winkelmann B
P2860
P356
10.1002/(SICI)1097-0045(20000501)43:2<77::AID-PROS1>3.0.CO;2-Q
P577
2000-05-01T00:00:00Z